Form 8-K - Current report:
SEC Accession No. 0000357097-16-000110
Filing Date
2016-01-04
Accepted
2016-01-04 08:05:35
Documents
6
Period of Report
2015-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fcsc010416form8-k.htm 8-K 38576
2 EXHIBIT 99.1 exhibit991eccagreement.htm EX-99.1 329961
3 EXHIBIT 99.2 exhibit992pressrelease.htm EX-99.2 18817
4 fibrocelllogocolornew.jpg GRAPHIC 581607
5 fibrocelllogocolornewpr.jpg GRAPHIC 581607
6 intrexonlogo.jpg GRAPHIC 6859
  Complete submission text file 0000357097-16-000110.txt   1992238
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 161316457
SIC: 2834 Pharmaceutical Preparations